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For the first time in 60 years we can afford to take an optimistic attitude
towards the poliomyelitis problem and its solution. In Sweden, notifica-
tion of poliomyelitis was introduced in 1905 and separate reporting of
paralytic and non-paralytic cases has been practiced since 1936. The records
are probably at least as complete and reliable as anywhere else in the world.
A graphic representation of the annual numbers of reported cases is found
in Figure 1.
In the period of 56 years covered by the diagram, the annual number of
cases has fluctuated considerably but certain trends may be traced. Larger
epidemics appear at roughly 5-year intervals, and particularly extensive
outbreaks are followed by a few calm years, especially noticeable after the
1911-12 and the 1953 epidemics. Furthermore, the years after the 1911-12
epidemic were characterized by a gradual increase in attack rates and a
gradual shift in age distribution of the paralytic cases. Counted on 5-year
periods beginning in 1916 the average annual reports, in chronological
order, amounted to 286, 347, 490, 703, 1293, 1714, 1424, and 1526 cases.
In 1911 only 12%o of patients with paralysis were over the age of 20 years;
the corresponding figures were 31%o in 1934; 48%o in 1944; and 57%o in
1953.
Vaccination Campaigns. Against this background, the course of events
after initiation of mass immunization with inactivated vaccine in the early
spring of 1957 assumes a definite significance. The approximate numbers
of persons given the primary two inoculations were 717,000 in 1957; in
consecutive subsequent years 358,000, 1.039.000, 620.000, and 1.200.000.
Hence, as of June 3, 1961, a total of about 4 million out of a population of
7.5 million. The first program comprised mainly children born in 1949-53;
the campaign was later gradually extended and now covers all persons
born in 1910 or later who are entitled to vaccination free of charge. The
approximate coverage as of June 1961 is, in the 6-month to 6-year-old
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group, 70%o; in age groups from 7-19 years, about 95%; in the groups
from 20-39 years, about 60% and from 40-51 years, about 45%.
Except for 1957 when about 650,000 children were given imported
vaccine, only a domestic product has been used. In the former group a total
of six cases of paralytic poliomyelitis have been reported, while so far not
a single verified case has occurred among a total of about 3.3 million per-
sons who have received at least two doses of Swedish vaccine. The total
number of paralytic cases in the pre-vaccination period from 1936 to 1956
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FIG. 1. Arrow indicates beginning of mass vaccination with inactivated vaccine.
varied betwen 300 and 3,400 annually with an average of 1136 cases; since
vaccination was introduced, the figures reveal 124 in 1957, 156 in 1958, 25
in 1959, 10 in 1960, and 0 in the first half of 1961.
This dramatic drop in case incidence to less than 1% in four years was
not expected. Even with a wild hope for a 100%o protective effect-which
actually seems to have materialized-one could not have anticipated a con-
commitant drastic reduction in attack rates among non-vaccinated persons.
However, from the annual average, 15 per 100,000 before introduction of
the vaccine, the case rate among non-vaccinated individuals dropped to
0.21 per 100,000 in 1960. It has to be taken into account that the age groups
which previously had the highest attack rates are those most thoroughly
covered by vaccination. As a result the age distribution of paralytic cases
shows a further shift, with about two-thirds now in persons over 20 years.
However, this fact alone cannot explain the phenomenon; even in the best
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immunized age groups, the fraction of non-vaccinated individuals exceeds
by four times the ratio of the 1960 attack rate to the previous average.
Virus Dissemination in the Community. Most likely, the reduction in
attack rate means but one thing-a reduction in the dissemination of wild
poliovirus strains in the country. A rational attempt to prove or disprove
such a suspicion would probably be by way of statistically weighted
sampling in repeated nation-wide surveys. Investigations of this kind have
not been performed and the only data available at present are the re-
TABLE 1. RECOVERY OF ENTERIC VIRUSES FROM HOSPITALIZED PATIENTS
IN 6-MONTH PERIODS, JANUARY 1958 THROUGH JUNE 1961.
RESULTS FROM VIRAL DIAGNOSTIC LABORATORIES IN
5 AREAS OF SWEDEN
1958 1959 1960 1961
1st 2nd 1st 2ntd 1st 2nd 1st
No. paralytic cases 156 25 10 (0)
No. specimens 5224 3962 2233
No. strains
poliovirus 9 117 42 39 6 10 1
non-polio-enterovirus 5 80 14 22 3 38 28
adenovirus 8 31 45 235 50 52 16
nontyped nonpoliovirus 2 88 22 17 5 0 0
Poliovirus % recovery (8.7)* 1.5 0.25 0.045
* Data from 1958 not quite comparable to those of subsequent years. Cf. text.
ports from the Public Health Laboratories in which virus diagnostic work
is carried out. Five such laboratories operate in Sweden, each serving a
different region.
This material does not meet even modest requirements of random
sampling. First, it refers almost exclusively to hospitalized patients. Since
suspicion of poliomyelitis with or without paralysis still is one of the pri-
mary reasons for requests for virologic examinations, a principle of selec-
tion is thereby introduced that presumably would favor the detection of any
circulating strains of poliovirus. However, it is impossible to evaluate the
amount of bias thus introduced or even to be certain about its direction.
Actually, in some hospitals, stool samples are examined routinely in the
virus diagnostic laboratory so that many samples tested did not come from
suspected cases of poliomyelitis. Furthermore, the nature and case incidence
of prevalent diseases will affect the extent of sampling as well as geo-
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graphic and age distribution involved. Finally, remote regions will tend
to be largely under-represented.
However, if in full awareness of the weaknesses of the material at hand,
the reports of virus isolations from stools (and a small number of throat
swabs) over the period January 1958 through June 1961 are compiled, the
results are as shown in Table 1. The following facts should be pointed out.
1) The number of poliovirus isolates is roughly in the same range as the
number of paralytic cases reported. In 1958 the occurrence of a case still
did not regularly incite a search for virus in the patient's environment. In
later years, as the number of cases dwindled, more interest was directed
toward investigations of the dissemination of poliovirus among household
and other contacts and a number of strains were thus recovered. It should
be pointed out that the majority of strains isolated from other than paralytic
or nonparalytic poliomyelitis patients were from healthy contacts of cases.
Very few isolations have been reported from individuals with no connection
with a known case, the only representatives of the latter category being 7
strains of type 3 virus recovered in 1959 by Kjellen (personal communica-
tion) in a systematic search for various viruses in a children's hospital
clientele.
2) The number of unidentified, non-poliovirus, cytopathogenic agents
has steadily decreased over the years, indicating improving diagnostic
facilities. For various reasons it may be assumed that in Sweden most of
these agents belonged in the adenovirus group.
3) The wave of adenovirus infections in 1959, almost exclusively type 7,
is conspicuous.
4) The number of non-polio-enterovirus isolates has been very moderate.
However, the relatively high recovery rate in the first 6 months of 1961
might indicate that these viruses now are on the increase.
5) Whereas the seasonal distribution of isolates of the other entero-
viruses is uneven-with 6 to 7 times more positives in the second than in
the first half of the year-a similar distribution of poliovirus isolates is
apparent only in 1958 but not at all in 1959 and 1960.
As already pointed out great caution must be used in interpreting these
observations. From the age distribution of serologic immunity found in
surveys of pre-vaccination samples1, the density of exposure during the
pre-vaccination era can be estimated at an average annual infection rate of
the order of about 10%o to 20%o of the susceptible population for each one
of the three types of poliovirus.
These figures represent the accumulated rates over the whole of one year.
Obviously the actual rate of infection at any one particular time would be
lower. Provided the sampling were uniformly distributed over the seasons,
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and the duration of virus excretion taken into consideration, the over all
annual recovery rates should be expected to be of the order of about 5%.
The actual recovery rates in Table 1 were 8.7% in 1958, 1.5%o in 1959,
0.25%o in 1960, and 0.045%o in the first half of 1961.
As already pointed out these figures cannot be taken at their face value.
As the fraction of susceptible individuals in a population decreases with
age, the infection rate must be expected to show a pronounced age
dependence, a feature clearly illustrated by Table 2. Obviously the age
distribution of the population sampled will strongly affect the over all
TABLE 2. POLIOVIRUS ISOLATIONS FROM STOOLS OF HOSPITALIZED PATIENTS
IN RELATION TO AGE OF SUBJECT. (STATE BACTERIOLOGICAL
LABORATORY, STOCKHOLM, 1958)
Age group No. specimens Positive % pos.
0-6 years 110 27 24.5
7-19 " 197 16 8.1
20-49 " 313 21 6.7
50+ " 77 3 4.0
Not stated 97 2
Total 794 69 8.7
recovery rates and, thus, the comparability of results. Examination of
the material in Table 1 in this respect has shown the proportion of the pre-
school age group to vary between 10%o and 14%o, and that of persons under
the age of 20 between 39%o and 46%o. Apparently these variations are too
slight to explain the 35-fold difference between the recovery rates in 1958
and 1960.
What is remarkable about Table 2 is not the correlation of percentages
of poliovirus isolations with age of the subjects, which was to be expected,
but rather the very high recovery rates themselves. In 1958 the paralytic
attack rate in non-vaccinated persons was 2.4 per 100,000, that is, about
17% of the pre-vaccination average. More than 90%o of the strains isolated
were of type 1 and the great majority of them derived from paralytic cases.
Under these conditions an over all recovery rate of 25%o in the pre-school
age group indicates that, except for poliomyelitis, few diseases calling for
virologic examination were prevalent in 1958. Consequently, the mode of
selection should introduce a strong bias favoring detection of polioviruses
and the recovery rates could not be considered representative of the occur-
rence of poliovirus infections in the population at large. In 1959 the situa-
tion was different. The wave of type 7 adenovirus infections dominated
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both in the hospital records and in the virus laboratory reports. Under
these conditions there is no reason to suspect an over-representation of
poliovirus isolations. On the other hand, it is not likely that adeno- and
polioviruses interfere one with the other and the conclusion would be, that
the figure in Table 1 might reasonably be a relatively true measure of the
actual poliovirus dissemination. Apparently, in 1960 neither enterovirus
nor adenovirus infection of the type now under consideration was pre-
valent; and in this instance too, we lack reason to suspect bias.
At the time of writing, there are no further detailed data for 1958 other
than those entered into the table. Thus, the recovery rate listed within
parenthesis does not refer to the total material but only to the laboratory
providing the material for Table 2. The true figure is, most probably, of
the same order, but this fact is a further reason for a cautious evaluation
of the trends. Taken together, all this seems to justify only a vague assump-
tion of a trend towards a gradual reduction in the dissemination of polio-
viruses in the period under study. Nonetheless, these data may be adduced
as evidence supporting other independent observations.
As a matter of fact such independent although indirect evidence exists.
In 1958 and 1959 pre-vaccination immunological surveys of groups with
about 100 children in each, children 3 to 5 years old, were conducted in
four different places in central Sweden. As far as antibodies to type 1 polio-
viruses were concerned, antibodies were detected in 0.1, and 3%o of three
groups studied. The fourth group came from a town where a small outbreak
of type 1 paralytic poliomyelitis had been observed in the fall of 1958. In
this group, examined in the following spring, 20%o had antibodies to type 1.
These findings indicate that during the preceding 3 to 5 years little or no
virus had been circulating in the society except in connection with scattered
local outbreaks of clinical disease.
Similar conclusions can be drawn from some previously reported results
of field tests with live type 1 (CHAT) poliovirus vaccine: in a school for
blind children 90%o of the age groups from 7 to 11 years, and 60%o of the
12 to 15-year-olds proved susceptible to infection'.
To all appearances, therefore, the incidence of paralytic poliomyelitis can
serve as a measure of the rate of dissemination of type 1 virus in the coun-
try, also in the post-epidemic period after 1953, which would mean a drastic
reduction when compared to the preceding 20-year period. The immuno-
logical surveys indicate that the same might be true of type 2, whereas
dissemination of type 3 probably has been somewhat less restricted. The
only reported isolations without some association to known cases of polio-
myelitis were the group of seven type 3 strains found in 1959 and mentioned
above.
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Theoretical Considerations. If these conclusions are accepted as probable,
it remains to find an explanation for the phenomenon of steadily declining
circulation of poliovirus. Apparently, as borne out by immunological sur-
veys carried out in 1957 before initiation of the vaccination campaigns, the
trend was then already established. This should not be surprising. The 1953
epidemic was more severe than any previous outbreak in Sweden, and un-
like those occurring during the preceding 20-year period which generally
were focal, it involved the whole country. Presumably, therefore, an ex-
tensive immunization of the population had taken place, and a considerable
resistance against dissemination of the virus type which was responsible
for the big epidemic should have been built up. In the following years other
enteroviruses dominated the picture, especially in 1957 when 13,000 cases
of aseptic meningitis were reported, cases with or without rash, associated
mainly with ECHO virus type 9. It is thus conceivable that interference
from other enteroviruses might have had a suppressive effect on the spread
of polioviruses, including those types to which no specific resistance was
present in large segments of the population.
In 1958, however, none of these restricting factors should have been
much in evidence. By then a population of pre-school age children had
accumulated, close to 100%o susceptible to all three types of poliovirus.
Other viruses, potentially capable of interference were scarce. Opportunities
for introduction of virulent strains of virus clearly existed, as epidemics
actually attacked Norway and Finland in 1958. As already mentioned, a
few local outbreaks did indeed occur, and some cases were identified as
apparently imported from Finland. However, in each such case the out-
break remained focal and no spread of virus seemed to occur beyond rather
narrow geographical boundaries.
Under these conditions a discussion of the possible effects of mass im-
munization with inactivated virus can hardly be avoided. Admittedly, it is
generally assumed that, while the use of live poliovirus vaccine can be ex-
pected to restrict radically the circulation of wild virus to the point of
eradication, immunization with inactivated vaccine neither produces com-
plete resistance to the natural infection nor does it affect significantly, the
multiplication of virus in the intestinal mucosa or its excretion in the feces.
Thus, inactivated vaccine would not be expected to interfere with the dis-
semination of wild virus strains. The question now raised is whether or not
this assumption is correct.
At the First International Conference on Live Poliovirus Vaccines in
1959 the results of the early Swedish small scale trials with live CHAT
type 1 virus were reported.8 It was then pointed out that in persons without
previous experience with live virus, but with antibodies after vaccination
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with inactivated vaccine, the course of infection was to a certain extent
dependent on the actual antibody titer at the time of exposure to live virus.
While none of the persons in this category were resistant to infection, the
average duration of the excretion following feeding of the virus was in-
versely related to the actual titer of circulating antibodies. As pointed out
by Bodian, this observation is in accord with Howe's finding concerning
the rate of type 2 virus excretion in artificially immunized chimpanzees'.
In 1958 Salk' also speculated over the declining attack rates in non-
vaccinated individuals which had been reported from several countries
where large scale vaccination had been initiated. As it later turned out,
after the "sobering experience" of the 1959 epidemic in the United States',
the optimistic interpretation these earlier observations received in many
quarters was hardly justified. In any event, Salk was inclined to regard the
reduced attack rates as an effect of the vaccination, reasoning as follows.
"If oropharyngeal secretions are more important for transmission of virus
in communities where contact with sewage or feces is less likely, and if
vaccination has little or no effect upon fecal virus but does have a signi-
ficant effect upon pharyngeal virus, then it is conceivable that spread of
virus may be diminished by effective vaccination . . ." The evidence sup-
porting the first if seems at best equivocal and as regards the second if,
evidence was at the time entirely lacking.
The New Orleans group' in their studies on the spread of virus found
no evidence to support the theory that oropharyngeal secretions are more
important than fecal excretion where the spread of the virus is concerned.
In fact, some of their observations spoke decidedly in favor of the assump-
tion of predominantly fecal spread. Our own observations on the decisive
importance of the age of the excreter point in the same direction2'3. Transi-
tion from the "pre-toilet trained" to "toilet trained age" was associated
with a 10-fold reduction in the rate of spread. Furthermore, in a group of
about 100 children, virus was detected in the throat in only a few and with-
out any demonstrable correlation with the character of spreader or non-
spreader.
It should be remembered, however, that these observations refer to virus
strains of extremely low infectivity. The virus concentration in secretions or
excretions must surpass a certain critical level to make transmission pos-
sible. This happens in the stools in only a fraction of infected persons. In
the throat the virus concentration usually is lower by several powers of
ten; the minimum oral infectious dose would represent such a volume as to
make contact infection mechanically and physiologically impossible. With
highly infective strains of virus the situation most certainly is different; in
such cases the two modes of transmission should be almost equally im-
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portant as far as infection by contact is concerned. However, the pos-
sibility of spread through additional channels, sewage, water, and flies
would seem always to give fecal excretion an edge. Under such conditions,
a reduction in pharyngeal excretion alone could hardly be expected to affect
significantly the volume of transmission in the community.
Such an assumption makes poor biological sense. We have to contend
that a biological mechanism becomes established only because its acquisition
confers a selective advantage. The defense mechanism here discussed would
provide protection to other persons but apparently offer no particular ad-
vantage to its possessor. If it did exert any selective pressure at all, it would
work in the wrong direction.
However, a defense mechanism of the general nature envisaged by Salk
does, indeed, seem to exist, although, quite logically, it probably involves
the whole of the target area of the virus and not only a limited part of it.
Admittedly, present evidence is fragmentary but yet sufficiently suggestive
to justify both further studies and some theorizing. Presumably, the
presence of antibodies in body fluids, and possibly in secretions, might serve
to reduce infection rates by neutralization of virus on the cell surface or
even before it reaches the cell. It would also form a kind of barrier against
extracellular spread of virus from the primarily infected cell to its neigh-
bours, and thus help in sealing off the original beach-head and limit the
volume of primary target tissue involved. This would probably lead to re-
duction in the amount of virus excreted as well as in duration of excretion.
The effect so far observed is indeed moderate; no reduction in infection
rates was observed and a significant shortening of the excretion period to
less than 2 weeks in no more than 6%o of the subjects, and then only in
those with antibody titers well above the average. It is debatable whether
this effect is sufficient to explain the radical change in the epidemiologic
situation.
However, it should be pointed out that the technic used in the trials
mentioned is not particularly well suited to a study of the present problem.
The live virus was always given in a dose of 106 TCID50. Since the maxi-
mum virus concentration in the stools after natural infection seems to vary
between 10O and 106 TCID5o, the dosage of vaccine virus given represents
an extremely severe challenge, corresponding to between 1 and 1000
grammes of infectious excretions, far in excess of anything likely to be
encountered under natural conditions. It is conceivable, and definitely prob-
able, that, had a more reasonable virus dose been given, a much more
differentiated picture would have been obtained. Apparently, this question
deserves a more systematic study, including actual determination of the 50%o
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oral infectious dose and its relation to the degree of serological immunity.
Such a study is in preparation.
DISCUSSION
The available evidence taken together seems to justify the working hypo-
thesis that effective immunization with inactivated virus does not only
confer protection against paralytic disease but might also produce a relative
resistance to oral infection or restrict virus multiplication and excretion, if
infection takes place.
The question will inevitably be raised why the Swedish experience seems
to differ from that of most other countries, notably the United States. With-
out pretending to have the right answer I would like to point out that com-
parative potency tests on domestic and various foreign vaccines, previously
reported8 indicated that the Swedish vaccines possessed a higher average
immunogenic potency (for type 1 from 6 to 10 times) and were more uni-
form. These findings, although disputed by some manufacturers, have been
borne out in systematic studies of conversion rates obtained in the field9 and
are also reflected in the surprisingly good protective effect thus far without
even a single vaccine failure having been observed in persons given at least
two doses.
A look into the Crystal Ball. There are certain reasons to believe that the
wild polioviruses might become more or less extinct as the use of vaccines,
inactivated as well as live, is extended. Taking the liberty of projecting
these speculations into the future, what will happen if and when the
classical polioviruses have all but disappeared? Will they leave a vacuum
behind, thereby preparing the ground for other viruses, at present, perhaps,
more or less suppressed, or will they make way for the emergence of new
agents?
Thus far, there is little substance to sustain such speculations. One fact
is just emerging, however. As the number of paralytic cases is declining,
and at the same time the diagnostic laboratory facilities are improving,
more attention can be payed to each individual suspected case, and sys-
tematic etiologic studies are now more or less routinely conducted. As a
result, a growing number of cases are observed which might previously
have been hidden under the diagnosis of poliomyelitis but are now rec-
ognized as being of a non-poliomyelitic etiology. Thus, cases of tick-born
encephalitis form a distinct group in which only the laboratory can provide
a definite diagnosis. Poliomyelitis, like manifestations of Coxsackie A, Cox-
sackie B, and ECHO-virus infections have likewise been described.10 Finally
there are several groups of cases in which all attempts to find a plausible
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etiology have failed to date. In this category are cases of facial paralysis,
radiculitis, and polyneuritis, including the Guillain-Barre syndrome and
Akureiri disease.
Whether or not such cases are tending to increase in numbers is not yet
clear. In any event no spectacular increase has so far occurred. As regards
other clinical manifestations of the nonpolio-enteroviruses, such as myo-
pathies, serositis, and aseptic meningitis associated with Coxsackie B, or
aseptic meningitis and rubella-like rash found with ECHO-viruses, these
manifestations seem to follow an epidemiological pattern much the same as
that of poliomyelitis, and independent thereof. One might expect, therefore,
that some of the enterovirus infections, now occurring mainly in early
childhood and producing insignificant symptoms or none at all, will later
reveal themselves as true diseases of civilization and present problems of a
similar nature as those associated with poliomyelitis. However, such a
development might occur independently of the presence or absence of polio-
viruses, since it would be entirely a question of the equilibrium between the
human host species and the particular type of virus.
It is true that the existence of a certain degree of interference between
enteroviruses is probable, and that, therefore, the disappearance of one type
might give more room for the others. In view of the great number of types
already recognized it is not likely, however, that disappearance of a few
members of the group would in any way radically change the ecologic
situation. In actual fact, if a hypothetical pressure of interference were re-
duced, dissemination would be less restricted and the effect, if any, would
be in a direction opposite to the one here envisaged, that is, the development
towards the state of a disease of civilization would be delayed rather than
favoured. Admittedly, the situation could be entirely different if one or more
of the poliovirus types interfered more specifically with some particular
virus, and especially if the virus did not belong to the enterovirus group.
Since it is a purely hypothetical case, however, the idea will not be dis-
cussed further in this regard.
On the basis of this reasoning I am inclined to believe that even a com-
plete eradication of the classical polioviruses would not leave any vacuum
behind and would not produce any drastic change in the situation as far as
other members of the enterovirus group are concerned.
Independently some other viruses such as those of hepatitis, mononucleo-
sis, herpes, and certain of the exanthemata might well be expected to assume
increasing importance which would call for specific prophylactic measures.
It is advisable to keep a close watch for such a possible development, so that
proper action can be taken before the situation becomes acute.
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Finally, a few words might be said about the question of new mutants.
The accumulating evidence indicates that most of the enteroviruses are
sufficiently closely related to be conceived of as derived from a single, or at
most, a few ancestral types. For instance, onthebasisofpresentevidence, seg-
regation of the classical polioviruses as a separate subgroup is not justified.
They represent rather one extreme of a gradient of decreasing invasiveness
and neuropathogenicity for man. If this concept is correct, the large number
of types of enteroviruses, although their evolution presumably spans un-
counted millennia, is still indication of a definite mutational capacity. There
are at present no hints as to the type of selective forces instrumental in the
emergence of new types. In such groups as the arborviruses, or above all
the myxoviruses, the antigenic relationships make plausible the assumption
of a selective pressure of an immunological nature. This is not applicable
to the enteroviruses.
Therefore, mass immunization cannot be expected to favour the establish-
ment of new variants of the classical polioviruses or of any other type of
enterovirus; so much less so, as the new post-vaccine era will mark a return
to the immunological status of the pre-hygienic era, in which the equilibrium
between the viruses and their human host was apparently established and
maintained without the occurrence of epidemics. With a drastic reduction
in the dissemination of virus the chances of mutation will also be propor-
tionally reduced.
To sum up, there seems to be no reason to expect any ominous second-
ary effects of an eventual eradication of the polioviruses. New diseases will
probably appear and existing ones assume increased medical importance in
the wake of poliomyelitis, but without causal relation to its disappearance.
The time to rest on our achievements can not yet be foreseen.
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